Affinity purified human antiphospholipid antibodies bind normal term placenta

Lupus

Volumn 8, Issue 7, 1999, Pages 525-531

  Donohoe, S ^a,b   Kingdom, J C P ^b   Mackie, I J ^b  

^a WATFORD GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

2 glycoprotein I; Antiphospholipid antibodies; Immunofluorescence; Placental proteins

Indexed keywords

CARDIOLIPIN; LIPOSOME; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY;

ANTIGEN BINDING; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BONE MARROW TRANSPLANTATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MALE; PATHOPHYSIOLOGY; PLACENTA; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY; TROPHOBLAST; WESTERN BLOTTING;

ABORTION, SPONTANEOUS; ANTIBODIES, ANTICARDIOLIPIN; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN G; MALE; PLACENTA; PREGNANCY; PROTEIN BINDING; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0032874599     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120399678840756     Document Type: Article

References (36)

1. Lockshin MD, Druzin ML, Goei S et al. Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus. N Eng J Med 1985; 313: 152-156.
2. Barbui T, Cortelazzo S, Galli M et al. Antiphospholipid antibodies in early repeated abortions: a case-controlled study Fertil Steril 1988; 50: 589-592.
3. Lockshin MD. Pathogenesis of the antiphospholipid antibody syndrome Lupus 1996; 5: 404-408.
4. Chamley LW, Pattison NS, McKay EJ. Elution of anticardiolipin antibodies and their cofactor beta-2-glycoprotein 1 from the placentae of patients with a poor obstetric history J Reprod Immunol 1993, 25: 209-220.
5. Katano K, Aoki K, Ogasawara M et al. Specific antiphospliolipid antibodies (aPL) eluted from placentae of pregnant women with aPL-positive sera. Lupus 1995; 4: 304-308.
6. Branch DW. Antiphospholipid antibodies and pregnancy: maternal implications. Semin Perinatol 1990; 14: 139-146.
7. Vogt E, Ng AK, Rote NS. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice. Am J Obstet Gynecol 1996, 174: 700-707
8. Katsuragawa H, Rote NS, Inoue T et al. Monoclonal antiphosphatidylserine antibody reactivity against human first-trimester placental trophoblasts. Am J Obstet Gynecol 1995; 172 1592-1597.
9. Abramowsky CR, Vegas ME, Swinehart G, Gyves MT. Decidual vasculopathy of the placenta in lupus erythematosus. N Engl J Med 1980; 303: 668-672
10. De Wolff, Carreras LO, Moerman P et al. Decidual vasculopathy and extensive placental infarction in a patient with repeated thromboembolic accidents, recurrent fetal loss, and a lupus anticoagulant. Am J Obstet Gynecol 1982, 142: 829-834.
11. Out HJ, Kooijman CD, Bruinse HW, Derksen RH. Histopathological findings in placentae from patients with intra-uterine fetal death and anti-phospholipid antibodies. Eur J Obstet Gynecol Reprod Biol 1991; 41: 179-186.
12. Erlendsson K, Steinsson K, Johannsson JH, Geirsson RT. Relation of antiphospholipid antibody and placental bed inflammatory vascular changes to the outcome of pregnancy in successive pregnancies of 2 women with systemic lupus erythematosus. J Rheumatol 1993; 20: 1779-1785.
13. Salafia CM, Cowchock FS. Plcental pathology and antiphospholipid antibodies: a descriptive study. Am J Perinatol 1997; 14: 435-441.
14. Salafia CM, Vintzileos AM, Silberman L et al. Placental pathology of idiopathic intrauterine growth retardation at term. Am J Perinatol 1992; 9: 179-184.
15. Triplet DA. New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies Haemostasis 1994; 24: 155-164.
16. Harris EN. Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group. Am J Clin Pathol 1990; 94: 476-484.
17. Harris EN, Baguley E, Asherson RA et al. Clinical and serological features of the 'antiphospholipid syndrome'. Br J Rheumatol 1987; 26.(Suppl 2):S19.
18. Alving CR, Richards RL. Immune reactivities of antibodies against glycolipids (I). Properties of anti-galactocerebroside antibodies purified by a novel technique of affinity binding to liposomes. Immunochemistry 1977; 14: 373-381.
19. Leach L, Eaton BM, Firth JA, Contractor SF. Immunogold localisation of endogenous immunoglobulin-G in ultrathin frozen sections of the human placenta. Cell Tissue Res 1989; 257: 603-607.
20. Kristoffersen EK, Matre R. Co-localization of the neontal Fc gamma receptor and IgG in human placental term syncytiotrophoblasts. Eur J Immunol 1996; 26: 1668-1671.
21. Malek A, Sager R, Kuhn P et al. Evolution of maternofetal transport of immunoglobulins during human pregnancy. Am J Reprod Immunol 1996; 36: 248-255.
22. Johnson PM, Natvig JB, Ystehede UA, Faulk WP. Immunological studies of human placentae: the distribution and character of immunoglobulins in chorionic villi. Clin Exp Immunol 1977; 30: 145-153.
23. Wood G, Reynard J, Krishnan E, Racela L. Immunobiology of the human placenta II. Localization of macrophages, in vivo bound IgG and C3. Cell Immunol 1978; 35: 205-216.
24. Ravirajan CT, Harmer I, McMally T et al. Phospholipid binding specificities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients with systemic lupus erythematosus. Ann Rheum Dis 1995; 54: 471-476.
25. Rote NS, Chang J, Katsuragawa H, Ng AK, Lyden TW, Mori T. Expression of phosphatidylserine-dependent antigens on the surface of differentiating BeWo human choriocarcinoma cells Am J Reprod Immunol 1995; 33: 114-121
26. Rand JH, Wu XX, Guller S et al. Reduction of annexin-V (placental anticoagulant protein-I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneous abortion. Am J Obsgtet Gynecol 1994; 171: 1566-1572.
27. Rand JH, Wu XX, Andree HA et al. Pregnancy loss in the antiphospholipid-antibody syndrome - a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154-160.
28. Faulk WP, Labarrere CA, Carson SD. Tissue factor: identification and characterization of cell types in human placentae. Blood 1990; 76: 86-96.
29. 2GPI and annexin V in villous placenta during normal and IUGR/APS pregnancies. J Soc Gynecol Invest 1998; 5: (abstract 56A)
30. Chamley LW, Allen JL, Johnson PM. Synthesis of beta2 glycoprotein 1 by the human placenta. Placenta 1997; 18: 403-410.
31. McNally T, Mackie IJ, Machin SJ, Isenberg DA. Increased levels of beta 2 glycoprotein-I antigen and beta 2 glycoprotein-1 binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome. Br J Rheumatol 1995; 34: 1031-1036.
32. Martinuzzo ME, Forastiero RR, Carreras LO. Anti beta 2 glycoprotein I antibodies: detection and association with thrombosis. Br J Haematol 1995; 89: 397-402.
33. McCrae KR, DeMichele AM, Pandhi P et al. Detection of antitrophoblast antibodies in the sera of patients with anticardiolipin antibodies and fetal loss. Blood 1993; 82: 2730-2741.
34. Del Papa N, Raschi E, Catelii L et al. Endothelial cells as a target for antiphospholipid antibodies: role of anti-beta 2 glycoprotein I antibodies. Am J Reprod Immunol 1997; 38: 212-217.
35. Hill MB, Phipps JL, Malia RG et al. Characterization and specificity of anti-endothelial cell membrane antibodies and their relationship to thrombosis in primary antiphospholipid syndrome (APS). Clin Exp Immunol 1995; 102: 368-372
36. Zhou Y, Fisher SJ, Janatpour M et al. Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion? J Clin Invest 1997; 99: 2139-2151.